Skip to main content
Log in

Management of autonomic dysfunction in severe tetanus: the use of magnesium sulphate and clonidine

  • Review Article
  • Published:
Intensive Care Medicine Aims and scope Submit manuscript

Abstract

The treatment of severe tetanus with autonomic dysfunction is discussed, with emphasis on the use of magnesium sulphate. An exemplary case is reported, describing the inadequate response to magnesium, but the previously unreported and successful use of clonidine to control sympathetic overactivity. The properties of clonidine are reviewed. Clonidine is felt to be a logical and appropriate drug for the treatment of autonomic dysfunction in severe tetanus.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Adams EB (1987) Tetanus. In: Weatherall DJ, Ledingham JGG, Warrell DA (eds) Oxford textbook of medicine, vol 2, 2nd edn. Oxford Medical Publications, Oxford, pp 265–270

    Google Scholar 

  2. Wright DK, Lalloo UG, Nayiager S, Govender P (1989) Autonomic nervous system dysfunction in severe tetanus; current perspectives. Crit Care Med 17:371–375

    Article  PubMed  CAS  Google Scholar 

  3. Kerr JH, Corbett JL, Prys-Roberts C, Crampton-Smith A, Spalding JMK (1968) Involvement of the sympathetic nervous system in tetanus. Lancet II:236–241

    Article  Google Scholar 

  4. Keilty SR, Gray RC, Dundee JW, McCulloch H (1968) Catecholamine levels in severe tetanus. Lancet II:195

    Article  Google Scholar 

  5. James MFM, Manson EDM (1985) The use of magnesium sulphate infusions in the management of very severe tetanus. Intensive Care Med 11:5–12

    Article  PubMed  CAS  Google Scholar 

  6. Trujillo MH, Castillo A, Espana J, Manzo A, Zerpa R (1987) Impact of intensive care management on the prognosis of tetanus. Analysis of 641 cases. Chest 92:63–65

    PubMed  CAS  Google Scholar 

  7. Prys-Roberts C, Corbett JL, Kerr JH, Crampton A, Spalding JMK (1969) Treatment of sympathetic overactivity in tetanus. Lancet I:542–545

    Article  Google Scholar 

  8. Alfery D, Rauscher A (1979) Tetanus: a review. Crit Care Med 7:176–181

    Article  PubMed  CAS  Google Scholar 

  9. Goldman M, Slovak J, Burns JR, Albertini RE (1979) Treatment of tetanus. JAMA 242:2761

    Article  PubMed  CAS  Google Scholar 

  10. Kanarek DJ, Kaufman B, Zwi S (1973) Severe sympathetic hyperactivity associated with tetanus. Arch Intern Med 132:602–604

    Article  PubMed  CAS  Google Scholar 

  11. Furste W (1980) Editorial. J Trauma 20:101–105

    PubMed  CAS  Google Scholar 

  12. Cole LB, Youngman HR (1969) Treatment of tetanus. Lancet I:1017–1020

    Article  Google Scholar 

  13. Dundee JW, Morrow WFK (1979) Labetolol in severe tetanus. Br Med J 1:1121–1122

    PubMed  CAS  Google Scholar 

  14. Wesley AG, Hariparsad D, Pather M, Rocke DA (1983) Labetolol in tetanus. The treatment of sympathetic nervous system overactivity. Anaesthesia 38:243–249

    PubMed  CAS  Google Scholar 

  15. Buchanan N, Smit L, Cane RD, Andrade M de (1978) Sympathetic overactivity in tetanus: fatality associated with propranolol. Br Med J 2:254–255

    PubMed  CAS  Google Scholar 

  16. Kerr J (1979) Current topics in tetanus. Intensive Care Med 5:105–110

    Article  PubMed  CAS  Google Scholar 

  17. Lipman J, James MFM, Erskine J, Plit ML, Eidelman J, Esser JD (1987) Autonomic dysfunction in severe tetanus: magnesium sulfate as an adjunct to deep sedation. Crit Care Med 15:987–988

    Article  PubMed  CAS  Google Scholar 

  18. Causon RC, Carruthers ME, Rodnight R (1981) Assay of plasma catecholamines by liquid chromatography with electrochemical detection. Anal Biochem 116:223–226

    Article  PubMed  CAS  Google Scholar 

  19. Woolmer R, Cates JE (1952) Succinylcholine in the treatment of tetanus. Lancet II:808–809

    Article  Google Scholar 

  20. Shackleton P (1954) The treatment of tetanus. Role of the anaesthetist. Lancet II:155–158

    Article  Google Scholar 

  21. Bjornboe M, Ibsen B, Johnson S (1954) Tetanus. A case treated with artificial respiration during 17 days. Dan Med Bull 1:129–131

    Google Scholar 

  22. Tseuda K, Oliver PB, Richter RW (1974) Cardiovascular manifestations of tetanus. Anesthesiology 40:588–591

    Article  Google Scholar 

  23. Edmondson RS, Flowers MW (1979) Intensive care in tetanus; management, complications and mortality in 100 cases. Br Med J 1:1401–1404

    PubMed  CAS  Google Scholar 

  24. Steptoe P, Fogh B (1986) Autonomt hyperaktivitetssyndrom ved tetanus. (The autonomic hyperactivity syndrom in tetanus) (in Danish) Ugeskr Laeger 148:2905–2907

    PubMed  CAS  Google Scholar 

  25. Hollow VM, Clarke GM (1975) Autonomic manifestations of tetanus. Anaesth Intensive Care 3:142–147

    PubMed  CAS  Google Scholar 

  26. Corbett JL, Kerr JH, Prys-Roberts C, Crampton-Smith A, Spalding JMK (1969) Cardiovascular disturbances in severe tetanus due to overactivity of the sympathetic nervous system. Anaesthesia 24:198–212

    Article  PubMed  CAS  Google Scholar 

  27. Toothill C, Dykes JRW, Ablett JJL (1970) Urinary catecholamine metabolite concentrations in tetanus. Br J Anaesth 42:524–530

    Article  PubMed  CAS  Google Scholar 

  28. Benedict CR, Kerr JH (1977) Assessment of sympathetic overactivity in tetanus. Br Med J 2:806

    PubMed  CAS  Google Scholar 

  29. Rocke DA, Wesley AG, Pather M, Calver AD, Hariparsad D (1986) Morphine in tetanus—the management of sympathetic nervous system overactivity. S Afr Med J 70:666–668

    PubMed  CAS  Google Scholar 

  30. Southorn PA, Blaise GA (1986) Treatment of tetanus-induced autonomic nervous system dysfunction with continuous epidural blockade. Crit Care Med 14:251–252

    Article  PubMed  CAS  Google Scholar 

  31. Jenkins M, Luhn N (1962) Active management of tetanus. Anesthesiology 23:690–709

    Article  PubMed  CAS  Google Scholar 

  32. Rie MA, Wilson RS (1978) Morphine therapy controls autonomic hyperactivity in tetanus. Ann Intern Med 88:653–654

    PubMed  CAS  Google Scholar 

  33. Buchanan N, Cane RD, Wolfson G, De Andrade (1979) Autonomic dysfunction in tetanus: the effects of a variety of therapeutic agents, with special reference to morphine. Intensive Care Med 5:65–68

    Article  PubMed  CAS  Google Scholar 

  34. Dasta JF, Brier KL, Kidwell GA, Schonfeld SA, Couri D (1981) Diazepam infusion in tetanus: correlation of drug levels with effect. South Med J 74:278–280

    PubMed  CAS  Google Scholar 

  35. Tekur U, Gupta A, Tayal G, Agrawal KK (1983) Blood concentrations of diazepam and its metabolites in children and neonates with tetanus. J Pediatr 102:145–147

    Article  PubMed  CAS  Google Scholar 

  36. Moir DD (1980) Obstetric anaesthesia and analgesia, 2nd edn. Bailliere Tindall, London

    Google Scholar 

  37. Mudge GH (1980) Agents affecting volume and composition of body fluids. In: Goodman Gilman A, Goodman, LS, Gilman A (eds) The pharmacological basis of therapeutics, 6th edn. MacMillan, New York, pp 879–883

    Google Scholar 

  38. Moore RM, Wingo WJ (1942) Blood level of magnesium ion in relation to lethal, anesthetic, analgesic and antitetanic effects. Am J Physiol 135:492–495

    CAS  Google Scholar 

  39. Peck CH, Meltzer SJ (1916) Anesthesia in human beings by intravenous injection of magnesium sulphate. JAMA 67:1131–1133

    CAS  Google Scholar 

  40. Mordes JP, Wacker WEC (1978) Excess magnesium. Pharmacol Rev 29:273–301

    Google Scholar 

  41. Cavenagh D, Knuppel RA (1981) Pre-eclampsia and eclampsia. In: Iffy L, Kaminitzky HA (eds) Principles and practice of obstetrics. Wiley, New York, pp 1271–1290

    Google Scholar 

  42. Rudd P, Blascke TK (1980) Anti-hypertensive agents and the drug therapy of hypertension. In: Goodman LS, Gilman A (eds) The pharmacological basis of therapeutics, 6th edn. MacMillan, New York, pp 797–799

    Google Scholar 

  43. Blake JA (1906) The use of magnesium sulphate in the production of anaesthesia and in the treatment of tetanus. Surg Gynecol Obstet 2:541–550

    Google Scholar 

  44. Brown AT, Campbell WAB (1978) Hazards of hypertonic magnesium enema therapy. Arch Dis Child 53:920

    PubMed  CAS  Google Scholar 

  45. Garcia-Webb P, Bhagat C, Oh T, Hart G, Thompson W (1984) Hypermagnesaemia and hyperphosphataemia after ingestion of magnesium phosphate. Br Med J 288:759

    CAS  Google Scholar 

  46. James MFM, Huddle KRL, Owen AD, Veen BW van der (1988) Use of magnesium sulphate in the anaesthetic management of phaeochromocytoma in pregnancy. Can J Anaesth 35:178–182

    Article  PubMed  CAS  Google Scholar 

  47. Wiberg JJ, Turner GG, Nuttall FQ (1978) Effect of phosphate or magnesium cathartics on serum calcium. Arch Intern Med 138:1114–1116

    Article  PubMed  CAS  Google Scholar 

  48. Bloor BC (1988) Clonidine and other alpha2 adrenergic agonists: an important new drug class for the perioperative period. Semin Anesth 7:170–177

    CAS  Google Scholar 

  49. Laverty R (1973) An account of the pharmacology of some antihypertensive drugs. Br Med Bull 29:152–157

    PubMed  CAS  Google Scholar 

  50. Metz SA, Halter JB, Porte D, Robertson RD (1978) Autonomic epilepsy: clonidine blockade of paroxysmal catecholamine release and flushing. Ann Intern Med 88:189–193

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sutton, D.N., Tremlett, M.R., Woodcock, T.E. et al. Management of autonomic dysfunction in severe tetanus: the use of magnesium sulphate and clonidine. Intensive Care Med 16, 75–80 (1990). https://doi.org/10.1007/BF02575297

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02575297

Key words

Navigation